Clinical trial
Evaluation of the Efficacy of Lactobacillus Crispatus M247 Administration in Promoting Clearance of Genital HR-HPV Infection and Modulating the Vaginal Microbiota: A Multicenter, Randomized, Placebo-Controlled, Single-Blind, Longitudinal, Prospective Clinical Trial
NCT06802809 is registered in ClinicalTrials.gov with Liaquat University of Medical & Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Lactobacillus Crispatus M247 Administration in Promoting Clearance of Genital HR-HPV Infection and Modulating the Vaginal Microbiota: A Multicenter, Randomized, Placebo-Controlled, Single-Blind, Longitudinal, Prospective Clinical Trial
- Lead sponsor
- Liaquat University of Medical & Health Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 5, 2022
- Completion date
- December 30, 2024
- Enrollment
- 66 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
human papillomavirus infection